PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25224F0012Japanese encephalitis vaccine (ixiaro — Valneva Usa, Inc

Valneva Usa, Inc holds $89.2M across 39 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent V797D70039. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Oct 2, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

252-Network Contract Office 12 (36C252)

Awarding office

Valneva Usa, Inc

Recipient

Oct 2, 2024

PoP end

$237K

Obligated

$242K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Valneva Usa, Inc — $90

Contract facts

Federal

Contract number36C25224F0012

Also listed as36C252-24-F-0012

Also listed asV797D70039-36C25224F0012

Agency252-Network Contract Office 12 (36C252)

Awarding office252-Network Contract Office 12 (36C252)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentValneva Usa, Inc

CAGE43FM1

UEINT38AFWQNKM7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVV797D70039

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 3, 2023

PoP end (current)Oct 2, 2024

Obligated$237K

Current value$242K

Potential value$242K

JAPANESE ENCEPHALITIS VACCINE (IXIARO) is a federal award for 252-Network Contract Office 12 (36C252) held by Valneva Usa, Inc. Estimated value $242K ($237K obligated). Current period of performance ends Oct 2, 2024. Last award drew 1 bidder. Place of performance: BETHESDA MD.

Recompete timing

Public

● Past PoP end (688 days ago)

Current PoP ended Oct 2, 2024 (688 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Valneva Usa, Inc — $89.2M obligated across 39 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($89.2M) · all agencies

Department of Defense (DOD)$86.4M · 97%Department of Veterans Affairs (VA)$2.0M · 2%Department of Health and Human Services (HHS)$675K · 1%Department of Justice (DOJ)$100K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C25226N0135

JAPANESE ENCEPHALITIS VIRUS VACCINE IXIARO

$720K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25224F0012?

36C25224F0012 (Japanese encephalitis vaccine (ixiaro) is a 252-Network Contract Office 12 (36C252) award with a potential value of $242K, currently held by Valneva Usa, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C252-24-F-0012?

36C252-24-F-0012 is the dashed form of PIID 36C25224F0012 (Japanese encephalitis vaccine (ixiaro), held by Valneva Usa, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25224F0012?

252-Network Contract Office 12 (36C252) awarded 36C25224F0012 to Valneva Usa, Inc (potential $242K).

Who is the incumbent on 36C25224F0012?

Valneva Usa, Inc is the incumbent with $89.2M across 39 related awards in SCOUT’s public footprint. The current period of performance ends Oct 2, 2024.

When does Valneva Usa, Inc’s 36C25224F0012 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 2, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 19, 2024